Summary of γδ CTL Clones
Clone* . | . | Vγ usage (RT-PCR) . | . | γδTCR expression§ . | . | Surface antigens (FACS®) . | . | Blocking of the cytotoxicity with antibody¶ . | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCRγδ . | . | TCRδ . | . | Vγ4 . | CD4/CD8‖ . | . | Thy-1 . | . | Ly-1 . | TL . | . | H-2 . | . | TCRδ≳≳ . | . | Lyt-2 . | . | Lyt-3 . | . | L3T4 . | ||||||
KC1-3 | 1/2‡ | + | + | − | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
1-7 | 4‡ | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
4-4 | 2/4‡ | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
4-8 | 1/2/4‡ | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
4-9 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
5-1 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
5-2 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
6-1 | 2/4‡ | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
6-2 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
7-3 | 1/2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
7-4 | 1/2‡ | + | + | − | DN | + | + | + | − | + | − | − | − | |||||||||||||
8-1 | 2/4 | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
8-3 | 2/4‡ | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
8-4 | 2/4 | + | + | + | DN | + | + | + | − | + | − | − | − |
Clone* . | . | Vγ usage (RT-PCR) . | . | γδTCR expression§ . | . | Surface antigens (FACS®) . | . | Blocking of the cytotoxicity with antibody¶ . | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCRγδ . | . | TCRδ . | . | Vγ4 . | CD4/CD8‖ . | . | Thy-1 . | . | Ly-1 . | TL . | . | H-2 . | . | TCRδ≳≳ . | . | Lyt-2 . | . | Lyt-3 . | . | L3T4 . | ||||||
KC1-3 | 1/2‡ | + | + | − | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
1-7 | 4‡ | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
4-4 | 2/4‡ | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
4-8 | 1/2/4‡ | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
4-9 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
5-1 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
5-2 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
6-1 | 2/4‡ | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
6-2 | 2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
7-3 | 1/2/4 | + | + | + | CD8αβ | + | + | + | − | + | + | + | − | |||||||||||||
7-4 | 1/2‡ | + | + | − | DN | + | + | + | − | + | − | − | − | |||||||||||||
8-1 | 2/4 | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
8-3 | 2/4‡ | + | + | + | DN | + | + | + | − | + | − | − | − | |||||||||||||
8-4 | 2/4 | + | + | + | DN | + | + | + | − | + | − | − | − |
The first digit of the clone name shows the origin of the mouse.
RT-PCR products were sequenced (see Fig. 6).
Expression of TCRγδ, TCRδ, and Vγ4 chains on the cell surface were detected by FACS® using moAb GL3, 3A10, and UC3-10A6, respectively.
Monoclonal antibodies to L3T4, Lyt-2 and Lyt-3 were used.
The target cells were Con A blasts of spleen cells from Tg.Con.3-1 (T3b-TL positive).
Monoclonal antibody 3A10 was used.